Cargando…

The effectiveness of an intervention designed based on health action process approach on diet and medication adherence among patients with type 2 diabetes: a randomized controlled trial

BACKGROUND: Diabetes is a major cause of worldwide morbidity and mortality. Diet and medication non-adherence are common among individuals with diabetes, making glycemic control difficult to attain. This study aimed to evaluate an intervention designed based on Health Action Process Approach (HAPA)...

Descripción completa

Detalles Bibliográficos
Autores principales: Ranjbaran, Soheila, Shojaeizadeh, Davoud, Dehdari, Tahereh, Yaseri, Mehdi, Shakibazadeh, Elham
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8725444/
https://www.ncbi.nlm.nih.gov/pubmed/34983628
http://dx.doi.org/10.1186/s13098-021-00773-x
_version_ 1784626118493470720
author Ranjbaran, Soheila
Shojaeizadeh, Davoud
Dehdari, Tahereh
Yaseri, Mehdi
Shakibazadeh, Elham
author_facet Ranjbaran, Soheila
Shojaeizadeh, Davoud
Dehdari, Tahereh
Yaseri, Mehdi
Shakibazadeh, Elham
author_sort Ranjbaran, Soheila
collection PubMed
description BACKGROUND: Diabetes is a major cause of worldwide morbidity and mortality. Diet and medication non-adherence are common among individuals with diabetes, making glycemic control difficult to attain. This study aimed to evaluate an intervention designed based on Health Action Process Approach (HAPA) to improve adherence to diet and medication among patients with type 2 diabetes in Tehran, Iran. METHODS: The study was a randomized controlled trial. A total of 248 patients with type 2 diabetes who had low diet and medication adherence were randomly allocated into two intervention (n  = 124) and control (n  = 124) groups. Intervention group received educational intervention during three months. HAPA constructs, diet and medication adherence, and Hemoglobin A1c (HbA1c) levels were assessed at baseline, one month and six months after the intervention. Mixed Model Analysis was used to compare between and within group changes in the outcomes. RESULTS: There was a statistically significant improvement in HbA1c levels after six months (7.77 ± 1.36% vs. 8.07 ± 1.52%, 95% CI, p  < 0.001). Diet and medication adherence, intention, task self-efficacy, coping self-efficacy, recovery self-efficacy, action and coping planning, barriers, benefits and perceived social support were significantly improved one month and six months after the intervention (p  < 0.001). CONCLUSION: Our intervention designed based on health action process approach led to improvements in diet and medication adherence, and HbA1c among the patients within one and six months. Trial registration: IRCT, IRCT20151208025431N4. Registered 10 March 2018, https://fa.irct.ir
format Online
Article
Text
id pubmed-8725444
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-87254442022-01-06 The effectiveness of an intervention designed based on health action process approach on diet and medication adherence among patients with type 2 diabetes: a randomized controlled trial Ranjbaran, Soheila Shojaeizadeh, Davoud Dehdari, Tahereh Yaseri, Mehdi Shakibazadeh, Elham Diabetol Metab Syndr Research BACKGROUND: Diabetes is a major cause of worldwide morbidity and mortality. Diet and medication non-adherence are common among individuals with diabetes, making glycemic control difficult to attain. This study aimed to evaluate an intervention designed based on Health Action Process Approach (HAPA) to improve adherence to diet and medication among patients with type 2 diabetes in Tehran, Iran. METHODS: The study was a randomized controlled trial. A total of 248 patients with type 2 diabetes who had low diet and medication adherence were randomly allocated into two intervention (n  = 124) and control (n  = 124) groups. Intervention group received educational intervention during three months. HAPA constructs, diet and medication adherence, and Hemoglobin A1c (HbA1c) levels were assessed at baseline, one month and six months after the intervention. Mixed Model Analysis was used to compare between and within group changes in the outcomes. RESULTS: There was a statistically significant improvement in HbA1c levels after six months (7.77 ± 1.36% vs. 8.07 ± 1.52%, 95% CI, p  < 0.001). Diet and medication adherence, intention, task self-efficacy, coping self-efficacy, recovery self-efficacy, action and coping planning, barriers, benefits and perceived social support were significantly improved one month and six months after the intervention (p  < 0.001). CONCLUSION: Our intervention designed based on health action process approach led to improvements in diet and medication adherence, and HbA1c among the patients within one and six months. Trial registration: IRCT, IRCT20151208025431N4. Registered 10 March 2018, https://fa.irct.ir BioMed Central 2022-01-04 /pmc/articles/PMC8725444/ /pubmed/34983628 http://dx.doi.org/10.1186/s13098-021-00773-x Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Ranjbaran, Soheila
Shojaeizadeh, Davoud
Dehdari, Tahereh
Yaseri, Mehdi
Shakibazadeh, Elham
The effectiveness of an intervention designed based on health action process approach on diet and medication adherence among patients with type 2 diabetes: a randomized controlled trial
title The effectiveness of an intervention designed based on health action process approach on diet and medication adherence among patients with type 2 diabetes: a randomized controlled trial
title_full The effectiveness of an intervention designed based on health action process approach on diet and medication adherence among patients with type 2 diabetes: a randomized controlled trial
title_fullStr The effectiveness of an intervention designed based on health action process approach on diet and medication adherence among patients with type 2 diabetes: a randomized controlled trial
title_full_unstemmed The effectiveness of an intervention designed based on health action process approach on diet and medication adherence among patients with type 2 diabetes: a randomized controlled trial
title_short The effectiveness of an intervention designed based on health action process approach on diet and medication adherence among patients with type 2 diabetes: a randomized controlled trial
title_sort effectiveness of an intervention designed based on health action process approach on diet and medication adherence among patients with type 2 diabetes: a randomized controlled trial
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8725444/
https://www.ncbi.nlm.nih.gov/pubmed/34983628
http://dx.doi.org/10.1186/s13098-021-00773-x
work_keys_str_mv AT ranjbaransoheila theeffectivenessofaninterventiondesignedbasedonhealthactionprocessapproachondietandmedicationadherenceamongpatientswithtype2diabetesarandomizedcontrolledtrial
AT shojaeizadehdavoud theeffectivenessofaninterventiondesignedbasedonhealthactionprocessapproachondietandmedicationadherenceamongpatientswithtype2diabetesarandomizedcontrolledtrial
AT dehdaritahereh theeffectivenessofaninterventiondesignedbasedonhealthactionprocessapproachondietandmedicationadherenceamongpatientswithtype2diabetesarandomizedcontrolledtrial
AT yaserimehdi theeffectivenessofaninterventiondesignedbasedonhealthactionprocessapproachondietandmedicationadherenceamongpatientswithtype2diabetesarandomizedcontrolledtrial
AT shakibazadehelham theeffectivenessofaninterventiondesignedbasedonhealthactionprocessapproachondietandmedicationadherenceamongpatientswithtype2diabetesarandomizedcontrolledtrial
AT ranjbaransoheila effectivenessofaninterventiondesignedbasedonhealthactionprocessapproachondietandmedicationadherenceamongpatientswithtype2diabetesarandomizedcontrolledtrial
AT shojaeizadehdavoud effectivenessofaninterventiondesignedbasedonhealthactionprocessapproachondietandmedicationadherenceamongpatientswithtype2diabetesarandomizedcontrolledtrial
AT dehdaritahereh effectivenessofaninterventiondesignedbasedonhealthactionprocessapproachondietandmedicationadherenceamongpatientswithtype2diabetesarandomizedcontrolledtrial
AT yaserimehdi effectivenessofaninterventiondesignedbasedonhealthactionprocessapproachondietandmedicationadherenceamongpatientswithtype2diabetesarandomizedcontrolledtrial
AT shakibazadehelham effectivenessofaninterventiondesignedbasedonhealthactionprocessapproachondietandmedicationadherenceamongpatientswithtype2diabetesarandomizedcontrolledtrial